RCUS ▼ -0.0% - Arcus Biosciences, Inc. $RCUS - Arcus Biosciences to Host Investor Event Featuring New Data for Casdatifan as a Treatment for Kidney Cancer Across Multiple Lines of Therapy Arcus Biosciences announced it will host an investor event to present new data on casdatifan, its experimental treatment for kidney cancer across multiple treatment settings. $RCUS showed no movement today despite the announcement, which may suggest the market had already priced in expectations for the upcoming data presentation or investors are awaiting the actual results before reacting. 22-SEP-2026 08:39 AM ET